Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019

9Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

From surveillance data of patients hospitalized with laboratory-confirmed influenza in the United States during the 2015-2016 through 2018-2019 seasons, initiation of antiviral treatment increased from 86% to 94%, with increases seen across all age groups. However, 62% started therapy ≥3 days after illness onset, driven by late presentation to care.

Cite

CITATION STYLE

APA

Tenforde, M. W., Cummings, C. N., O’Halloran, A. C., Rothrock, G., Kirley, P. D., Alden, N. B., … Garg, S. (2023). Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019. Open Forum Infectious Diseases, 10(1). https://doi.org/10.1093/ofid/ofac681

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free